Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mesencephalic cholinergic nuclei in progressive supranuclear palsy.

J L Juncos1, E C Hirsch, S Malessa

  • 1Laboratoire de Médecine Expérimentale, INSERM U-289, Paris, France.

Neurology
|January 1, 1991
PubMed
Summary

Progressive supranuclear palsy (PSP) causes significant loss of choline acetyltransferase (ChAT) neurons in specific brain areas. This study quantises this cell loss in mesencephalic nuclei, revealing regionally selective neurodegeneration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

STochastic Optical Reconstruction Microscopy (STORM) reveals the nanoscale organization of pathological aggregates in human brain.

Neuropathology and applied neurobiology·2020
Same author

Cognitive deficit, and neuropathological correlates, in the oldest-old.

Revue neurologique·2020
Same author

Xenon-mediated neuroprotection in response to sustained, low-level excitotoxic stress.

Cell death discovery·2016
Same author

Neuroprotective and neurorestorative potential of xenon.

Cell death & disease·2016
Same author

[Spreading of protein misfolding: A new paradigm in neurology].

Revue neurologique·2015
Same author

Piperazine derivatives as iron chelators: a potential application in neurobiology.

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine·2015

Area of Science:

  • Neuroscience
  • Neuropathology
  • Neurochemistry

Background:

  • Progressive supranuclear palsy (PSP) is a neurodegenerative disease with poorly understood mechanisms.
  • Cholinergic pathways are implicated in various neurological functions and diseases.
  • Identifying specific neuronal populations affected in PSP is crucial for understanding disease progression.

Purpose of the Study:

  • To investigate the distribution and quantity of choline acetyltransferase (ChAT)-immunoreactive neurons in mesencephalic nuclei of individuals with PSP.
  • To determine if PSP involves a selective loss of cholinergic neurons in specific brain regions.

Main Methods:

  • Autopsy brain tissue from 3 PSP cases and 4 controls was analyzed.
  • An antibody against choline acetyltransferase (ChAT) was used to identify cholinergic neurons.

Related Experiment Videos

  • ChAT-immunoreactive neurons were quantified in specific mesencephalic nuclei along the rostrocaudal axis.

    • Main Results:

    • A significant reduction in ChAT-immunoreactive neurons was observed in PSP cases compared to controls.
    • Marked cell loss was found in the nucleus of Edinger-Westphal (69%), rostral interstitial nucleus of the medial longitudinal fasciculus (97%), interstitial nucleus of Cajal (78%), and deep superior colliculus (93%).
    • No significant difference in ChAT-immunoreactive cell bodies was found in cranial nerves III and IV, mesencephalic reticular formation, or parabigeminal nucleus.

    Conclusions:

    • The findings support the hypothesis of regionally selective destruction of cholinergic neurons in Progressive Supranuclear Palsy.
    • This selective neurodegeneration may contribute to the clinical manifestations of PSP.
    • Further research into these specific cholinergic deficits could inform therapeutic strategies for PSP.